Carcinoid cancers arise from the neuroendocrine cell system of the gastrointestinal tract, lungs, and other organs. Hepatic metastases are common, and patients often suffer from endocrinopathies secondary to tumor secretion of various hormones and peptides. As complete surgical resection is often not possible because of widespread disease, new therapeutic and palliative treatments are needed. In this study, we characterized the effects of suberoyl bishydroxamic acid (SBHA), a histone deacetylase inhibitor, on the growth and neuroendocrine phenotype of carcinoid cancer cells. SBHA treatment of human gastrointestinal and pulmonary carcinoid cancer cells resulted in a dose-dependent inhibition of cell proliferation. Western blot analysis showed a decrease in cyclin D1 and an increase in p21 and p27, indicating that the mechanism of this growth inhibition is cell cycle arrest. Furthermore, SBHA treatment suppressed two neuroendocrine tumor markers, chromogranin A and achaete-scute complex-like 1. These changes in the growth and neuroendocrine phenotype of carcinoid cells were associated with activation of the Notch1 signaling cascade. We conclude that SBHA shows promise as a potential anticancer agent for the treatment of patients with advanced carcinoid tumor disease.
Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells. Publishing Authors By Initials
Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells. Journal Published:
PUBLICATION TYPE: Research Support, Non-U.S. Gov
Journal: Journal of gastrointestinal surgery : official jou
VOLUME: 11
Page Numbers: 1515-20; discussion 1520
Journal Abbreviation: J. Gastrointest. Surg.
ISSN: 1091-255X
DAY: 15
MONTH: 09
YEAR: 2007
Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9706084
Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells.
AFFILIATION: Endocrine Surgery Research Laboratories, Department of Surgery, University of Wisconsin, Madison, WI 53792, USA.
Country: United States
AGENCY: United States NIDDK
GRANT: DK066169
ACRONYM: DK
MEDLINETA: J Gastrointest Surg
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells Related Publications